KIF23 promotes cervical cancer progression via inhibiting NLRP3‐mediated pyroptosis
Article in The FASEB Journal (May 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Impact of Chemotherapeutic Agents on PD-L1, CTLA-4, and VISTA Gene Expression in Cervical Cancer Cell Lines: An In Vitro Study
Article in Indian Journal of Gynecologic Oncology (April 2024)
Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study
Article in Clinical Cancer Research (February 2024)